NDC11 51759036117
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51759-0361-17 | 51759-0361 |
| 51759-361-17 | 51759-361 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 2d19a877-1f5a-4731-800a-dddadc424080 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 51759-361-17 51759-361 51759036117 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.